| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2020 ( Subtotal = -$328,304 ) |
| | 2020 | 2015 | GALENEA CORP. | 300 TECHNOLOGY SQ STE 2 | CAMBRIDGE | MA | 02139-3520 | MIDDLESEX | USA | R01MH093450 | Electrophysiological Endophenotypes of Schizophrenia in Mouse and Man | 000 | 4 | NIH | 5/14/2020 | -$328,304 |
|
| Issue Date FY: 2018 ( Subtotal = -$235,779 ) |
| | 2018 | 2016 | GALENEA CORP. | | | | | | | R01MH093450 | Electrophysiological Endophenotypes of Schizophrenia in Mouse and Man | 000 | 5 | NIH | 8/22/2018 | -$235,779 |
|
| Issue Date FY: 2016 ( Subtotal = $561,808 ) |
| | 2016 | 2016 | GALENEA CORPORATION | 790 MEMORIAL DRIVE | CAMBRIDGE | MA | 02139 | MIDDLESEX | USA | R01MH093450 | Electrophysiological Endophenotypes of Schizophrenia in Mouse and Man | 000 | 5 | NIH | 5/19/2016 | $561,808 |
|
| Issue Date FY: 2015 ( Subtotal = $576,919 ) |
| | 2015 | 2015 | GALENEA CORPORATION | 790 MEMORIAL DRIVE | CAMBRIDGE | MA | 02139 | MIDDLESEX | USA | R01MH093450 | Electrophysiological Endophenotypes of Schizophrenia in Mouse and Man | 000 | 4 | NIH | 6/11/2015 | $576,919 |
|
| Issue Date FY: 2014 ( Subtotal = $563,678 ) |
| | 2014 | 2014 | GALENEA CORPORATION | 790 MEMORIAL DRIVE | CAMBRIDGE | MA | 02139 | MIDDLESEX | USA | R01MH093450 | Electrophysiological Endophenotypes of Schizophrenia in Mouse and Man | 000 | 3 | NIH | 8/5/2014 | $563,678 |
|
| Issue Date FY: 2013 ( Subtotal = $575,438 ) |
| | 2013 | 2013 | GALENEA CORPORATION | 790 MEMORIAL DRIVE | CAMBRIDGE | MA | 02139 | MIDDLESEX | USA | R01MH093450 | Electrophysiological Endophenotypes of Schizophrenia in Mouse and Man | 000 | 2 | NIH | 5/22/2013 | $575,438 |
| | 2013 | 2010 | GALENEA CORPORATION | 790 MEMORIAL DRIVE | CAMBRIDGE | MA | 02139 | MIDDLESEX | USA | RC4MH092889 | MECHANISM-BASED, PRO-COGNITIVE THERAPIES FOR SCHIZOPHRENIA | 000 | 1 | NIH | 5/7/2013 | $0 |
|
| Issue Date FY: 2012 ( Subtotal = $1,284,918 ) |
| | 2012 | 2012 | GALENEA CORPORATION | 790 MEMORIAL DRIVE | CAMBRIDGE | MA | 02139 | MIDDLESEX | USA | R43MH092962 | NOVEL SEROTONERGIC, PRO-COGNITIVE ANTIPSYCHOTIC THERAPIES | 000 | 2 | NIH | 9/11/2012 | $346,141 |
| | 2012 | 2012 | GALENEA CORPORATION | 790 MEMORIAL DRIVE | CAMBRIDGE | MA | 02139 | MIDDLESEX | USA | R01MH093450 | Electrophysiological Endophenotypes of Schizophrenia in Mouse and Man | 000 | 1 | NIH | 7/26/2012 | $625,924 |
| | 2012 | 2012 | GALENEA CORPORATION | 790 MEMORIAL DRIVE | CAMBRIDGE | MA | 02139 | MIDDLESEX | USA | R43MH093029 | IN VITRO TOOLS FOR PRECLINICAL ANALYSIS OF COGNITIVE THERAPIES FOR SCHIZOPHRENIA | 000 | 2 | NIH | 9/13/2012 | $312,853 |
| | 2012 | 2010 | GALENEA CORPORATION | 790 MEMORIAL DRIVE | CAMBRIDGE | MA | 02139 | MIDDLESEX | USA | RC4MH092889 | MECHANISM-BASED, PRO-COGNITIVE THERAPIES FOR SCHIZOPHRENIA | 000 | 1 | NIH | 6/26/2012 | $0 |
|
| Issue Date FY: 2011 ( Subtotal = $661,452 ) |
| | 2011 | 2011 | GALENEA CORPORATION | 790 MEMORIAL DRIVE | CAMBRIDGE | MA | 02139 | MIDDLESEX | USA | R43MH092962 | NOVEL SEROTONERGIC, PRO-COGNITIVE ANTIPSYCHOTIC THERAPIES | 000 | 1 | NIH | 8/31/2011 | $349,802 |
| | 2011 | 2011 | GALENEA CORPORATION | 790 MEMORIAL DRIVE | CAMBRIDGE | MA | 02139 | MIDDLESEX | USA | R43MH093029 | IN VITRO TOOLS FOR PRECLINICAL ANALYSIS OF COGNITIVE THERAPIES FOR SCHIZOPHRENIA | 000 | 1 | NIH | 7/28/2011 | $311,650 |
|
| Issue Date FY: 2010 ( Subtotal = $5,144,711 ) |
| | 2010 | 2010 | GALENEA CORPORATION | 790 MEMORIAL DRIVE | CAMBRIDGE | MA | 02139 | MIDDLESEX | USA | RC1MH088617 | IN VIVO METHODS FOR PRECLINICAL ANALYSIS OF COGNITIVE THERAPIES FOR SCHIZOPHRENIA | 002 | 2 | NIH | 8/17/2010 | $533,641 |
| | 2010 | 2010 | GALENEA CORPORATION | 790 MEMORIAL DRIVE | CAMBRIDGE | MA | 02139 | MIDDLESEX | USA | RC4MH092889 | MECHANISM-BASED, PRO-COGNITIVE THERAPIES FOR SCHIZOPHRENIA | 000 | 1 | NIH | 9/27/2010 | $4,484,789 |
| | 2010 | 2009 | GALENEA CORPORATION | 790 MEMORIAL DRIVE | CAMBRIDGE | MA | 02139 | MIDDLESEX | USA | RC1MH088617 | IN VIVO METHODS FOR PRECLINICAL ANALYSIS OF COGNITIVE THERAPIES FOR SCHIZOPHRENIA | 000 | 1 | NIH | 4/5/2010 | $0 |
| | 2010 | 2009 | GALENEA CORPORATION | 790 MEMORIAL DRIVE | CAMBRIDGE | MA | 02139 | MIDDLESEX | USA | RC1MH088617 | IN VIVO METHODS FOR PRECLINICAL ANALYSIS OF COGNITIVE THERAPIES FOR SCHIZOPHRENIA | 001 | 1 | NIH | 7/29/2010 | $126,281 |
|
| Issue Date FY: 2009 ( Subtotal = $403,689 ) |
| | 2009 | 2009 | GALENEA CORPORATION | 790 MEMORIAL DRIVE | CAMBRIDGE | MA | 02139 | MIDDLESEX | USA | RC1MH088617 | IN VIVO METHODS FOR PRECLINICAL ANALYSIS OF COGNITIVE THERAPIES FOR SCHIZOPHRENIA | 000 | 1 | NIH | 9/29/2009 | $403,689 |
|
| Issue Date FY: 2005 ( Subtotal = $383,410 ) |
| | 2005 | 2005 | GALENEA CORPORATION | 790 MEMORIAL DRIVE | CAMBRIDGE | MA | 02139 | MIDDLESEX | USA | R43AI066472 | DEVELOPMENT OF SIRNAS TO PREVENT AND TREAT INFLUENZA INFECTION | 000 | 1 | NIH | 8/15/2005 | $383,410 |
|
|
